ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Dermata Therapeutics Inc

Dermata Therapeutics Inc (DRMA)

0.3427
0.0026
(0.76%)
At close: April 26 4:00PM
0.3427
0.0026
( 0.76% )
After Hours: 5:50PM

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
0.3427
Bid
0.3183
Ask
0.35
Volume
16,675
0.3325 Day's Range 0.3583
0.237372 52 Week Range 2.8101
Market Cap
Previous Close
0.3401
Open
0.346
Last Trade
1
@
0.355
Last Trade Time
17:50:06
Financial Volume
$ 5,659
VWAP
0.339386
Average Volume (3m)
128,124
Shares Outstanding
3,189,034
Dividend Yield
-
PE Ratio
-0.14
Earnings Per Share (EPS)
-2.44
Revenue
-
Net Profit
-7.8M

About Dermata Therapeutics Inc

Dermata Therapeutics Inc is a clinical-stage medical dermatology company focused on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical and aesthetic skin conditions and diseases. Its two product candidates, DMT310 and DMT410, incorporate its p... Dermata Therapeutics Inc is a clinical-stage medical dermatology company focused on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical and aesthetic skin conditions and diseases. Its two product candidates, DMT310 and DMT410, incorporate its proprietary, multifaceted, Spongilla technology to topically treat a variety of dermatological conditions. Its Spongilla technology platform will enable to develop and formulate singular and combination products that are able to target topical delivery of chemical compounds into the dermis for maximum treatment effect for a variety of inflammatory skin diseases. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Wilmington, Delaware, USA
Founded
1970
Dermata Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker DRMA. The last closing price for Dermata Therapeutics was $0.34. Over the last year, Dermata Therapeutics shares have traded in a share price range of $ 0.237372 to $ 2.8101.

Dermata Therapeutics currently has 3,189,034 shares outstanding. The market capitalization of Dermata Therapeutics is $1.08 million. Dermata Therapeutics has a price to earnings ratio (PE ratio) of -0.14.

DRMA Latest News

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.00451.330573625070.33820.35830.321233220.34152567CS
4-0.0573-14.3250.40.44440.2373721834160.30393691CS
12-0.1193-25.82251082250.4620.5080.2373721281240.37111882CS
26-0.3127-47.71132133050.65540.9750.2373725344700.61913564CS
52-1.5773-82.15104166671.922.81010.2373723761950.92552032CS
156-92.4573-99.630711206992.8111.20.23737278491210.47307353CS
260-92.4573-99.630711206992.8111.20.23737278491210.47307353CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
FLJFLJ Group Limited
$ 0.705
(28.18%)
1.36M
SBETSharpLink Gaming Inc
$ 1.17
(12.49%)
2.45k
BRFHBarfresh Food Group Inc
$ 1.56
(10.64%)
19.31k
LINKInterlink Electronics Inc
$ 6.11
(9.89%)
208
PEVPhoenix Motor Inc
$ 0.65
(9.61%)
900
CLVRClever Leaves Holdings Inc
$ 1.45
(-64.72%)
150.16k
FCUVFocus Universal Inc
$ 0.2852
(-11.51%)
263.82k
GNTAGenenta Science SPA
$ 2.35
(-9.27%)
3.03k
CACOCaravelle International Group
$ 0.9078
(-9.22%)
95.33k
ILAGIntelligent Living Application Group Inc
$ 0.6325
(-8.68%)
19.57k
IVPInspire Veterinary Partners Inc
$ 0.0429
(-2.50%)
13.63M
FFIEFaraday Future Intelligent Electric Inc
$ 0.0435
(-7.45%)
7.08M
PEGYPineapple Energy Inc
$ 0.0636
(1.60%)
4.44M
BRSHBruush Oral Care Inc
$ 0.0595
(0.85%)
3.72M
SOFISoFi Technologies Inc
$ 8.1198
(3.17%)
3.62M

DRMA Discussion

View Posts
Monksdream Monksdream 1 week ago
DRMA new 52 lo
👍️0
glenn1919 glenn1919 1 month ago
DRMA...............................https://stockcharts.com/h-sc/ui?s=DRMA&p=W&b=5&g=0&id=p86431144783
👍️0
Monksdream Monksdream 2 months ago
DRMA10QnduebMarchb6
👍️0
glenn1919 glenn1919 4 months ago
DRMA.................................https://stockcharts.com/h-sc/ui?s=DRMA&p=W&b=5&g=0&id=p86431144783
👍️0
Zorro Zorro 4 months ago
Might have a good AH again.
👍️0
Invest-in-America Invest-in-America 4 months ago
DRMA: And when all is said & done, a classic TOILET FLUSH!!! (Heck with this shit, I'm goin' back to Vegas!!)
👍️0
Pnypnchr Pnypnchr 4 months ago
Yep I'm well. Same to you as well.

Gonna try to jump in here in the AM if it don't get too far gone.
👍️0
subslover subslover 4 months ago
Thank you, buddy! Hope you're doing well and happy new year!
👍️0
Pnypnchr Pnypnchr 4 months ago
Absolutely, nice move here.
👍️0
subslover subslover 4 months ago
Win or loose I had to take a shot. You know me well lol
👍️0
TheFinalCD TheFinalCD 4 months ago
NICE BUYS, BETTER LATE THAN NEVER
👍️0
subslover subslover 4 months ago
Zorro just filled at $1.12 now gonna sleep on it lol
👍️0
subslover subslover 4 months ago
Nothing makes sense anymore! Most of the Pink Sheets have no liquidity anymore. This BS on the NASDAQ is the only game of chance lol
👍️0
subslover subslover 4 months ago
I'm jumping in now
👍️0
Zorro Zorro 4 months ago
Must be time to buy:
https://www.barchart.com/stocks/quotes/DRMA/opinion
👍️0
TheFinalCD TheFinalCD 4 months ago
GOOD ALERT ON NEWS, THE CHART IS A PRIME EXAMPLE OF HOW CRAZY THIS MARKET REALLY IS

https://finviz.com/quote.ashx?t=DRMA&ty=c&ta=1&p=d
👍️0
Zorro Zorro 4 months ago
Nice catch!
👍️0
Zorro Zorro 4 months ago
Lol! Scared money doesn't make any. Sometimes you just have to go with your instincts.
👍️0
Invest-in-America Invest-in-America 4 months ago
DRMAW (Warrants): Closed UP by 153% today in the OPEN Market --- before the Post-M news even hit (Insiders at work).
👍️0
subslover subslover 4 months ago
I have to think a good chunk of that 7 million offering got bought. I'm thinking about taking a slice on a dip because IMHO this could fly past $2.00 tomorrow. Total game of craps but I'm a compulsive gambler :)
👍️0
Zorro Zorro 4 months ago
Always the guess with AH. Dang MM like to play early PM.
👍️0
subslover subslover 4 months ago
This baby is flying to new heights! Will be interesting how she does tomorrow
👍️0
Zorro Zorro 4 months ago
Might have more gas in the tank.
👍️0
Zorro Zorro 4 months ago
Made some nice money on the warrants if they sold.
👍️0
subslover subslover 4 months ago
Here you go, buddy https://www.otcmarkets.com/filing/html?id=17107805&guid=eyJ-kpcUPOVAB3h
👍️0
Zorro Zorro 4 months ago
Thanks! At what price if you know. OVER 7m just traded.
👍️0
subslover subslover 4 months ago
I used to trade this one. Haven't seen it in a while. There is an offering for 7.1 million shares
👍️0
Zorro Zorro 4 months ago
Was wondering why it was moving. Low floater 3.54M worth keeping an eye on.. Thanks for posting.
👍️0
subslover subslover 4 months ago
NEWS
Dermata Expands Global Intellectual Patent Portfolio with Issuance of Japanese Patent for DMT410 for the Treatment of Hyperhidrosis
- This is the Company's first patent issued for DMT410, using its Spongilla technology to topically deliver botulinum toxin for hyperhidrosis -
- The Company is currently discussing partnership opportunities to advance development of DMT410 -
- In 2022, the Japanese prevalence of hyperhidrosis was 10%, with approximately 6% having primary axillary hyperhidrosis -

SAN DIEGO, CA / ACCESSWIRE / January 4, 2024 / Dermata Therapeutics, Inc. (Nasdaq:DRMA, DRMAW) ("Dermata" or the "Company"), a late-stage biotechnology company focusing on the treatment of medical and aesthetic skin conditions, today announced the issuance of a new patent in Japan for its DMT410 program for the treatment of hyperhidrosis. The patent, entitled "Compositions for the treatment of skin conditions," (Japanese Patent No. 7395576) further strengthens Dermata's intellectual property for DMT410 for the treatment of hyperhidrosis and could lead to further protections for additional indications.

"We believe this patent issuance further validates DMT410's novel concept to easily deliver botulinum toxin topically instead of requiring patients to receive multiple injections," says Gerry Proehl, Dermata's Chairman, President, and CEO. "We are excited about the opportunities the DMT410 program can bring to patients, not only for the treatment of axillary hyperhidrosis as we have seen in our proof-of-concept study, but potentially for palmer and plantar hyperhidrosis which has no currently approved products. We also believe there are opportunities to use DMT410 to treat many aesthetic skin conditions like reducing pore number and size, decreasing sebum production, and reducing fine lines and wrinkles, all while improving the look and quality of facial skin," continued Mr. Proehl. "We also believe this new patent could aid us in our partnership discussions with a company that has a botulinum toxin to further develop the DMT410 program for multiple indications."

About DMT410
👍️0
$oldier Hard $oldier Hard 4 months ago
$DRMA rolling in A/Hs.
👍️0
mick mick 4 months ago
https://www.otcmarkets.com/stock/DRMA
👍️0
tw0122 tw0122 5 months ago
Flying to $1.10 back to .70s back to .80s has volume
👍️0
$oldier Hard $oldier Hard 6 months ago
Gap filled from this mornings opening and may be consolidating now.
👍️0
mick mick 6 months ago
https://www.otcmarkets.com/stock/DRMA
👍️0
glenn1919 glenn1919 6 months ago
DRMA................................https://stockcharts.com/h-sc/ui?s=DRMA&p=W&b=5&g=0&id=p86431144783
👍️0
$oldier Hard $oldier Hard 6 months ago
$DRMA low floater 2.9 mil, heavily oversold, might have to start buying a few of this one.
👍️0
Monksdream Monksdream 6 months ago
DRMA new 52 week low
👍️0
Monksdream Monksdream 7 months ago
DRMA new 52 wewek low
👍️0
Monksdream Monksdream 7 months ago
DRMA under $2
👍️0
mick mick 7 months ago
https://www.otcmarkets.com/stock/DRMA
👍️0
mick mick 8 months ago
$drma Recent DRMA News
Form 8-K - Current report • Edgar (US Regulatory) • 08/10/2023 08:18:20 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/10/2023 08:16:30 PM
👍️0
mick mick 8 months ago
$drma
Form 8-K - Current report • Edgar (US Regulatory) • 08/03/2023 08:31:21 PM
Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 07/28/2023 04:15:22 AM
👍️0
mick mick 8 months ago
$DRMA Form 424B4 - Prospectus [Rule 424(b)(4)] • Edgar (US Regulatory) • 07/27/2023 08:50:42 PM
Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 07/07/2023 08:21:18 PM
👍️0
mick mick 8 months ago
nice chart
https://stockcharts.com/c-sc/sc?s=DRMA&p=D&yr=1&mn=1&dy=0&i=p24986097784&a=1113701411&r=1693595168175
👍️0
The Night Stalker The Night Stalker 10 months ago
good news and it goes red
👍️0
The Night Stalker The Night Stalker 10 months ago
good news and it goes red
👍️0
The Night Stalker The Night Stalker 10 months ago
https://www.otcmarkets.com/stock/DRMA/news/story?e&id=2564690
👍️0
tw0122 tw0122 10 months ago
Run run $1.90s
👍️0
The Night Stalker The Night Stalker 10 months ago
https://stockcharts.com/h-sc/ui?s=drma&p=D&yr=1&mn=1&dy=0&id=p24986097784&listNum=23&a=1113701411
👍️0
The Night Stalker The Night Stalker 10 months ago
hit 1.94 0n a few blocks, good news and a big volume spike runs it
👍️0

Your Recent History

Delayed Upgrade Clock